Avidity Partners Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-382,305
Closed -$18.4M 84
2023
Q3
$18.4M Sell
382,305
-152,695
-29% -$9.07M 0.74% 49
2023
Q2
$36.5M Sell
535,000
-533,200
-50% -$34.4M 1.28% 34
2023
Q1
$51.8M Sell
1,068,200
-1,884,800
-64% -$99.6M 1.72% 22
2022
Q4
$178M Buy
2,953,000
+986,000
+50% +$57.7M 3.85% 6
2022
Q3
$119M Buy
+1,967,000
New +$62.2M 2.42% 10
2021
Q3
Sell
-182,000
Closed -$9.36M 126
2021
Q2
$9.36M Buy
+182,000
New +$5.68M 0.25% 70

Other funds holding PRTA

Avidity Partners Management's PRTA Position: Q4 2023 in Review

Avidity Partners Management sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 382,305 shares — an estimated $18.4M sold.

Avidity Partners Management first reported a position in PRTA in Q2 2021 and held it in 6 quarters. The position peaked at $178M in Q4 2022. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • Avidity Partners Management reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • Avidity Partners Management sold 382,305 Prothena Corp shares in Q4 2023, an estimated $18.4M.
  • Avidity Partners Management first reported a position in Prothena Corp in Q2 2021 and held it in 6 quarters.
  • Avidity Partners Management's Prothena Corp position peaked at $178M in Q4 2022.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Avidity Partners Management's 13F filing for Q4 2023, filed 14 Feb 2024.